Insider Transactions Reported by 22 Insiders of SANGAMO THERAPEUTICS, INC

Symbol
SGMO on Nasdaq
Location
Richmond, CA

There are no Buy or Sell transactions made by insiders since 05 Jan 2025

SANGAMO THERAPEUTICS, INC executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
BIOGEN INC. 10%+ Owner $6,745,007 26 Sep 2023
Sandy Macrae PRESIDENT, CEO AND DIRECTOR, Director $853,835 24 Nov 2025
Nathalie Dubois-Stringfellow Svp Chief Development Officer $299,870 24 Nov 2025
Scott Willoughby Svp, Chief Legal Officer, Secy $292,489 24 Nov 2025
Prathyusha Duraibabu Principal Financial Officer $290,252 24 Nov 2025
Amy Pooler Vp, Head Of Research $166,774 24 Aug 2024
Nikunj Jain Principal Accounting Officer $102,365 24 Nov 2025
David Mark McClung EVP, Chief Operating Officer $81,185 25 Nov 2023
Gregory D. Davis Head of Research & Technology $80,733 24 Nov 2025
Rolf Andrew Ramelmeier EVP, Technical Operations $65,518 25 May 2023
Jason D. Fontenot SVP, Chief Scientific Officer $52,069 25 Nov 2023
PARKER H STEWART Director $51,796 12 Jun 2025
Karen L. Smith Director $46,966 12 Jun 2025
Kenneth J. Hillan Director $45,816 12 Jun 2025
Robert Carey Director $45,816 12 Jun 2025
James R. Meyers Director $45,816 12 Jun 2025
John Markels Director $44,336 12 Jun 2025
Courtney Beers Director $38,019 12 Jun 2025
Margaret Horn Director $38,019 12 Jun 2025
Robert J. Schott SVP, Head of Development $28,863 25 Feb 2022
Joseph S. Zakrzewski Director $23,193 25 Feb 2022
Saira Ramasastry Director $13,641 25 Feb 2022

Recent Insider Transactions by Companies or Individuals for SANGAMO THERAPEUTICS, INC

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.